S
Zodix
Study
Academic Library
Search
Shelves
Open access
Sign in
Search or jump to…
⌘K
Hye-Young Kwon · Study
Home
/
Author
Hye-Young Kwon
7 works
· latest 2021
· 3 institutions
cluster: provisional
ORCID 0000-0001-9772-1354
Follow
Suggest an ORCID correction
h-index
7
i10
7
Citations
602
Works here
7
13
18
20
21
Most cited in this library
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets
2018 · 159 citations
Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future
2020 · 114 citations
Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries
2013 · 86 citations
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications
2021 · 75 citations
Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?
2020 · 57 citations
Works
7 shown
Evidence-based public policy making for medicines across countries: findings and implications for the future
Journal of Comparative Effectiveness Research
·
2021
·
19 authors
·
review
·
Open access
55
citations
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications
Expert Review of Pharmacoeconomics & Outcomes Research
·
2021
·
50 authors
·
Open access
75
citations
Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future
Frontiers in Public Health
·
2020
·
25 authors
·
Open access
114
citations
Integrative Review of Managed Entry Agreements: Chances and Limitations
PharmacoEconomics
·
2020
·
34 authors
·
review
·
Open access
56
citations
Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?
Frontiers in Pharmacology
·
2020
·
6 authors
·
Open access
57
citations
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets
Frontiers in Public Health
·
2018
·
52 authors
·
review
·
Open access
159
citations
Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries
Expert Review of Pharmacoeconomics & Outcomes Research
·
2013
·
6 authors
·
review
86
citations